| Original language | English |
|---|---|
| Pages (from-to) | 2668-2669 |
| Number of pages | 2 |
| Journal | European Journal of Nuclear Medicine and Molecular Imaging |
| Volume | 48 |
| Issue number | 9 |
| DOIs | |
| State | Published - Aug 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, No. 9, 08.2021, p. 2668-2669.
Research output: Contribution to journal › Editorial
TY - JOUR
T1 - 2021
T2 - the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
AU - Herrmann, Ken
AU - Kratochwil, Clemens
AU - Fendler, Wolfgang P.
AU - Eiber, Matthias
AU - Hustinx, Roland
N1 - Funding Information: The authors are active Nuclear Medicine practitioners and true believers in theranostics. Ken Herrmann reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics and personal fees from Pharma15, outside the submitted work. Clemens Kratochwil is a co-inventor of the PSMA-617 patent. Wolfgang P. Fendler was a consultant for BTG, and he received fees from RadioMedix, Bayer and Parexel outside of the submitted work. Matthias Eiber reports prior consulting activities for Blue Earth Diagnostics, Progenics Pharmaceuticals and Point Biopharma and a patent application for rhPSMA outside of the submitted work. No further conflicts of interest in regard to this letter to the editor.
PY - 2021/8
Y1 - 2021/8
UR - http://www.scopus.com/inward/record.url?scp=85106413525&partnerID=8YFLogxK
U2 - 10.1007/s00259-021-05409-w
DO - 10.1007/s00259-021-05409-w
M3 - Editorial
C2 - 34021392
AN - SCOPUS:85106413525
SN - 1619-7070
VL - 48
SP - 2668
EP - 2669
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
IS - 9
ER -